Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.67 |
| ▸ | CA1 | P00915 | 2/20 | 0.67 |
| ▸ | CA9 | Q16790 | 2/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NT5E | P21589 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12793541 | 0.83 | CA12 (0.71) | CA12CA1CA9CA2LMNA | |
| SCHEMBL20118964 | 0.80 | CA1 (1.00) | CA12CA1CA9CA2LMNA | |
| SCHEMBL11478927 | 0.80 | CA12 (0.67) | CA12CA1CA9CA2LMNA | |
| Sulfuric Acid SCHEMBL1535692 | 0.78 | CA12 (0.54) | CA12CA1CA9CA2LMNA | |
| SCHEMBL11022463 | 0.78 | AR (0.44) | CA12CA1CA9CA2LMNA | |
| SCHEMBL1830817 | 0.78 | MGLL (0.62) | LMNAALDH1A1TSHRNT5E | |
| SCHEMBL11028524 | 0.77 | CA2 (0.43) | CA12CA1CA9CA2LMNA | |
| SCHEMBL4837136 | 0.76 | MGLL (0.60) | LMNAALDH1A1TSHRNT5E | |
| SCHEMBL18181415 | 0.76 | GAA (0.52) | CA12CA1CA9CA2LMNA | |
| SCHEMBL12793823 | 0.76 | ALDH1A1 (0.68) | CA12CA1CA9CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723425-B2 | Pigment compositions with modified ATRP copolymer dispersants | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-05-25 | — | — | US | claimed |
| US-20210139423-A1 | CHEMICAL MODULATORS OF STORE-OPERATED CALCIUM CHANNELS AND THEIR THERAPEUTIC APPLICATIONS | THE TEXAS A&M UNIVERSITY SYSTEM | 2021-05-13 | — | — | US | disclosed |
| US-20190092723-A1 | CHEMICAL MODULATORS OF STORE-OPERATED CALCIUM CHANNELS AND THEIR THERAPEUTIC APPLICATIONS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2019-03-28 | — | — | US | disclosed |
| EP-1465935-B1 | PIGMENT COMPOSITIONS WITH MODIFIED ATRP COPOLYMER DISPERSANTS | BASF SE (DE) | 2016-09-07 | — | — | EP | disclosed |
| EP-2411437-B9 | COMPOSITION COMPRISING STABLE POLYOL MIXTURES | BYK CHEMIE GMBH (DE) | 2013-07-31 | — | — | EP | disclosed |
| EP-2411437-B1 | COMPOSITION COMPRISING STABLE POLYOL MIXTURES | BYK CHEMIE GMBH (DE) | 2013-05-08 | — | — | EP | disclosed |
| EP-1611197-B1 | LIGHT STABILISING POLYMER DISPERSANTS IN PIGMENT DISPERSIONS | BASF SE (DE) | 2012-03-21 | — | — | EP | disclosed |
| US-20120029104-A1 | COMPOSITION COMPRISING STABLE POLYOL MIXTURES | BYK-CHEMIE GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| EP-2411437-A2 | COMPOSITION COMPRISING STABLE POLYOL MIXTURES | BYK-Chemie GmbH (DE) | 2012-02-01 | — | — | EP | disclosed |
| US-20120003583-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-01-05 | — | — | US | disclosed |
| US-20120003583-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-01-05 | — | — | US | disclosed |
| WO-2010108672-A2 | COMPOSITION COMPRISING STABLE POLYOL MIXTURES | BYK-CHEMIE GMBH (DE) | 2010-09-30 | — | — | WO | disclosed |
| US-20060229407-A1 | Light stabilising polymer dispersants in pigment dispersions | CIBA SPECIALTY CHEMICALS CORP. | 2006-10-12 | — | — | US | disclosed |
| US-20060160940-A1 | Process for intercalating natural or szynthetic clays with block or comb copolymers | CIBA SPECIALTY CHEMICALS CORP. | 2006-07-20 | — | — | US | disclosed |
| US-6849679-B2 | Pigment compositions with modified block copolymer dispersants | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139423-A1 | CHEMICAL MODULATORS OF STORE-OPERATED CALCIUM CHANNELS AND THEIR THERAPEUTIC APPLICATIONS | ORAI1, SARAF, CACNA1C | CA12 2684/4885CA1 399/4885CA9 3130/4885 |
| US-20190092723-A1 | CHEMICAL MODULATORS OF STORE-OPERATED CALCIUM CHANNELS AND THEIR THERAPEUTIC APPLICATIONS | ORAI1, SARAF, CACNA1C | CA12 2684/4885CA1 399/4885CA9 3130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.